Deutsch
Recombinant proteins are essential tools in modern life science research. From cell culture and immunology to drug discovery and advanced therapies, they enable breakthroughs across disciplines. But not all proteins are created equal.
TargetMol’s white paper reveals how a catalog of over 13,000 recombinant proteins can elevate your experiments to the next level.
Why Recombinant Proteins Matter
Recombinant proteins produced via DNA/RNA technology offer significant advantages over natural sources:
-
High yield and reproducibility
-
Controlled quality and purity
-
Broad range of species, tags, and modifications
This makes them ideal for applications such as:
-
Cell-based assays and culture
-
Protein structure and function studies
-
Immunology and virology research
-
Drug discovery and development
-
Cell and gene therapy
What TargetMol Offers
-
Comprehensive portfolio: Cytokines, growth factors, CAR-T targets, checkpoint proteins, enzymes, viral proteins, and more
-
Flexible expression systems: E. coli, HEK293, insect cells, yeast, cell-free systems, and virus-like particles
-
Validated quality: Each product undergoes SDS-PAGE, HPLC, and biological activity testing. Most products have endotoxin levels below 1 EU/μg, some even under 0.01 EU/μg
-
Product highlight: Human TNF-alpha (TMPY-00936) demonstrates exceptional activity with an ED50 as low as 3–30 pg/mL in cytotoxicity assays
Application-Specific Product Highlights
Cytokines
-
EGF – Human, E. coli, tag-free
-
M-CSF – Mouse, HEK293, tag-free
-
TNF-alpha – Human, E. coli, tag-free
CAR-T Therapy Targets
-
HER2 – Human, HEK293
-
EGFR – Human, HEK293, His tag
-
BCMA – Human, HEK293, His tag
Immune Checkpoint Proteins
-
PD-1 – Human, HEK293, His tag
-
CTLA-4 – Human, HEK293, tag-free
-
TIM-3 – Human, HEK293, His tag
Viral Antigens
-
Hemagglutinin – Influenza A H3N2
-
gp120 – HIV-1
-
Fusion Glycoprotein – RSV
